High expression of MIP1-β is linked to anti-tumor responses through chemoattraction of lymphocytes (T and NK cells) in esophageal SCC and colorectal adenocarcinomas (36–38). The gene discussed is CCL4; the disease is esophageal squamous cell carcinoma.